IDM Pharma, Inc. Reports Third Quarter 2006 Financial Results

13 Nov 2006

·www.biospace.com

Financial Statement

IRVINE, Calif.--(BUSINESS WIRE)--IDM Pharma, Inc. (Nasdaq: IDMI) today announced its financial results for the quarter and the nine months ended September 30, 2006. Financial information for the periods ended September 30, 2006 represents the consolidated results of IDM Pharma (formerly Epimmune Inc.) and its subsidiary, IDM S.A., following the completion of their business combination on August 16, 2005. Financial information for prior periods represents the historical financial information for IDM S.A. which was deemed to be the acquirer in the business combination for accounting purposes.

Organizations

Epimmune, Inc.

IDM Pharma, Inc.Idm

Indications

Targets

Drugs

Hot reports

Global Drug R&D Express (Apr 2024)

PatSnap Synapse

Global Drug R&D Express (Mar 2024)

PatSnap Synapse

Global Drug R&D Express (Feb 2024)

PatSnap Synapse

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.